Drug eluting stents in AMI: Keep the data coming

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 6, 2008, Pages 770-771

  Vetrovec, George W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; BARE METAL STENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPARATIVE STUDY; DEATH; DRUG ELUTING STENT; HUMAN; NOTE; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; STENT; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; METALS; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; PROSTHESIS DESIGN; RECURRENCE; RISK ASSESSMENT; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 43249111982     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21586     Document Type: Note

References (4)

1. Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;355:1105-1113.
2. Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093-1104.
3. Pasceri V, Patti G, Speciale G, et al. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 2007;153:749-754.
4. Sianos G, Papafaklis MI, Daemen J, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction. The importance of thrombus burden. J Am Coll Cardiol 2007;50:573-583.